Advertisement

Topics

New dosing regimen brings Mylotarg reapproval for Pfizer

06:53 EDT 5 Sep 2017 | BioPharma-Reporter

Original Article: New dosing regimen brings Mylotarg reapproval for Pfizer

NEXT ARTICLE

More From BioPortfolio on "New dosing regimen brings Mylotarg reapproval for Pfizer"

Quick Search
Advertisement
 

Relevant Topics

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...